Background. Pneumonia is now the second leading cause of death for children aged <5 years worldwide. However, analyses of the long-term evolution of under-5 mortality from pneumonia are still scarce in the literature. We aimed to explore long-term trends of under-5 mortality from pneumonia in 56 countries from 1960 to 2012.
There were an estimated 6.3 million deaths in children aged <5 years in 2013, and approximately 15% were caused by pneumonia [1] . In the last decade, there has been a substantial reduction in pneumonia deaths among children, from 1.7 million deaths globally in 2000 to 1.3 million deaths in 2011 [2] . However, these improvements have been inconsistent across countries, for example, the yearly rate of decline in childhood pneumonia mortality for several countries was far higher than the fourth Millennium Development Goal (MDG-4) target rate of 4.4%, whereas other countries' yearly rates of decline were much lower [2] . Common risk factors for pneumonia death, such as maternal education, undernutrition, and overcrowding [3, 4] , are strongly correlated with socioeconomic factors that have changed dramatically in recent decades. It is of major public health interest to assess temporal patterns of pneumonia mortality in children aged <5 years by national economic development categories to gain better insights into how economic growth influences pneumonia mortality trends in these children.
Since the late 1980s, researchers have tried to estimate the global burden of acute respiratory infections [5, 6] . The 21st century has seen even greater efforts, mainly led by the Child Health Epidemiology Reference Group (CHERG) and their partners [2, [7] [8] [9] [10] . However, these estimates are primarily the burden estimates for a given year and are not informative regarding longitudinal changes in childhood mortality. Therefore, to our limited knowledge, the analyses of the longterm evolution of under-5 mortality from pneumonia remain poorly described. Historical temporal trends of pneumonia in children aged <5 years may provide valuable information for further intervention planning and priority setting.
The World Health Organization (WHO) mortality database collates historical vital registration data disaggregated by age and gender [11] . We analyzed data on under-5 pneumonia mortality for 56 countries extracted from this WHO mortality database between 1960 and 2012 by gender and examined the long-term trends. In addition, we also explored whether the temporal trends of under-5 mortality from pneumonia were different between countries with different economic development trajectories in recent decades.
METHODS

Data Sources
We accessed mortality data from the WHO mortality database in June 2016. The database includes numbers and causes of death (International Classification of Diseases (ICD; 7th-10th revisions 7-10) at the country level by age and sex, as reported by WHO member states from their civil registration systems since 1950. The quality of the mortality data had been evaluated by the WHO [12] using quality criteria based on the completeness of civil registration systems and the spare use of codes for ill-defined causes.
We included data for the period from 1960 (when all countries had relatively high completeness of death data) to 2012 (data availability after this year was variable). The corresponding population data were also extracted from the WHO mortality database, or the estimates of population were taken from the World Population Prospects, 2015 revision [13] . We determined the underlying cause of death from pneumonia using ICD 7-10 codes (see Supplementary Materials Table 1 for more details). The WHO mortality database disaggregates deaths into neonatal and post-neonatal periods, but they do not disaggregate the population into corresponding groups. We therefore aggregated data only within the age group of <5 years, stratified by sex.
Because the continuity and completeness of data vary between countries and few countries have continuous data from 1960 onward, we decided to include countries that had at least 30 years of under-5 pneumonia death data and corresponding population data over our predefined period . Ultimately, we included 56 countries.
To determine a country's economic development trajectory, we used the World Bank's country classification by income level. National income per capita reflects the value of all final products; as several of these products can be expected to influence mortality, it is likely the best single indicator of living standards in a country [14] . We classified countries according to national income group transitions between the middle 1980s (when the World Bank's new classification criteria were first available) and 2012 [15] . We classified all 56 included countries into 4 groups: group A, high-income to high-income countries (H-H countries); group B, lowermiddle-income to lower-middle-income countries or uppermiddle-income to upper-middle-income countries (LM-LM or UM-UM countries); group C, lower-middle-income to upper-middle-income countries (LM-UM countries); and group D, lower-middle-income to high-income countries or upper-middle-income to high-income countries (LM-H or UM-H countries; see Table 1 ).
Statistical Analyses
We computed mortality for pneumonia per 100 000 individuals by gender. To graphically demonstrate the temporal trends of under-5 mortality from pneumonia, we plotted the mortality trends using both the observed data and locally weighted regression (lowest) smoothed data [16, 17] . Furthermore, we used joinpoint regression analysis to detect distinct periods with different slopes and estimate the annual percent of changes (APCs) of each period [18] ; the APC is calculated as APCi = [(Exp(bi) − 1)] × 100, where bi represents the slope of the period [19] . Joinpoint regression analysis fits a series of joined linear models of the natural logarithm of annual mortality using calendar year as an independent variable [18] . We allowed a maximum of 5 joinpoints for estimation, and we used the Bayesian information criterion to select the best-fit model. We also estimated the average annual percent change (AAPC), assuming only 1 segment for the full range of our study periods [20] . Joinpoint regression analyses were conducted with Joinpoint Regression Program version 4.1.1 (Statistical Research and Applications Branch, National Cancer Institute). All other analyses were conducted with R version 2.15.2 (R Foundation for Statistical Computing, Vienna, Austria). Table 1 summarizes the characteristics of all included countries. In the 56 included countries, there were 110 million children aged <5 years in 2012, which accounted for approximately 20% of global children aged <5 years in that same year. Of the 56 countries, 23 were classified as group A, H-H countries; 11 were included in group B, LM-LM or UM-UM countries; 11 were in group C, LM-UM countries; and the remaining 11 were in group D, LM-H or UM-H countries. Figure 1 provides an overview of the evolution of under-5 pneumonia mortality by sex between 1960 and 2012. Mortality from pneumonia decreased overall by 93.9% in boys and by 94.2% in girls. Although mortality from pneumonia has substantially decreased in both genders, there was a moderately higher pneumonia mortality in boys compared with girls across the study period (Supplementary Materials Figure 1 ). Figure 1 also presents the timeline of ICD version transitions in our study, which shows that the transition from ICD-7 to ICD-8 had the greatest impact on under-5 mortality from pneumonia around 1968. However, the subsequent transitions to ICD-9 and ICD-10 only had minimal effects on mortality.
RESULTS
Overall Changes in Under-5 Mortality From Pneumonia
We also plotted the temporal trends of smoothed under-5 pneumonia mortality by sex for each included country (Supplementary Materials Figure 2 ). There were few within-group variations of temporal trends in group A and group D, and the burden of pneumonia declined monotonically in almost all group A and group D countries. However, in group B, no single homogeneous pattern could be observed. While an overall decrease was observed in all group B countries, several countries, such as Paraguay and Venezuela, experienced upward trajectories over the study period. The trajectories were more consistent in group C than in group B, and most countries had a constant downward trend except for the Dominican Republic. Figure 2 and Table 2 demonstrate the temporal under-5 pneumonia mortality trends by national income transition group. In absolute terms, under-5 mortality from pneumonia in group D countries has decreased by 99.1% from 1960 to 2012. In contrast, childhood mortality from pneumonia has decreased by only 85.6% in group B. As displayed in Figure 2 , there were different temporal trends of pneumonia mortality between the country groups. For example, declines in group D and group A were more monotonic. Although both group B and group C had an overall downward trend, the patterns were more variable. and 1995 (APC, −3.9%; 95% CI, −4.5% to −3.3%). The results by national income transition group indicate that group D countries had the largest decrease over the entire period, with an AAPC of −8.7% (95% CI, −10.1% to −7.3%). Mortality decline in group D was characterized by 4 statistically significant periods. There were 2 "fast-track" reduction periods, from 1970 to 1974 (APC, −15.8%; 95% CI, −17.3% to −14.3%) and from 1974 to 1984 (APC, −10.7%; 95% CI, −15.9% to −5.2%), and 2 additional moderately declining periods from 1960 to 1967 with an APC of −6.1% (95% CI, −7.2% to −5.0%) and from 1998 to 2012 with an APC of −8.8% (95% CI, −10.0% to −7.6%) in group D. Trend changes for group A countries were similar to those for group D countries, but group A countries had a very fast-track decline in the early 1960s (APC, −17.9%; 95% CI, −22.9% to −12.6%). Notably, joinpoint analysis did not find any fast-track decrease period in group B countries but found only 2 moderate decrease periods from 1986 to 1995 (APC, −4.1%; 95% CI, −6.2% to −1.9%) and from 1995 to 2012 (APC, −8.8%; 95% CI, −10.0% to −7.7%). Trend changes were similar in group C except that the first moderate decrease period was observed between 1970 and 1983 (APC, −7.2%; 95% CI, −8.6% to −5.7%).
Pneumonia Mortality Trends by National Income Transition Group
Results of Joinpoint Regression Analyses
DISCUSSION
Here, we present an overview of pneumonia mortality trends in children aged <5 years in 56 countries over a 50-year period. Several noteworthy findings have been revealed in our study. First, there was a substantial decrease in overall mortality from pneumonia in children aged <5 years over the past 5 decades, and economic development may modify this trend. Second, despite the significant decline in pneumonia mortality in both boys and girls, there was a moderately higher pneumonia mortality in boys compared with girls throughout the study period. Third, the joinpoint analysis identified 3 statistically significant pneumonia mortality decline periods. This information, along with knowledge from outside of our study, may inform hypotheses about why such changes occurred and could provide helpful information for further interventions.
We present a unique picture of childhood pneumonia mortality trends in 56 countries with distinct income levels over more than 5 decades; this makes comparisons with previous studies difficult. However, the magnitude of mortality reduction in recent decades identified in our study is similar to that reported in another study. For example, our study indicated that childhood mortality from pneumonia declined by 43% between 2000 and 2012, which is comparable with the >30% reduction reported in the CHERG's study between 2000 and 2013 [1] . In addition, our study reveals large variations in the rate and absolute terms of mortality decline, with distinct gradients across national income transition groups. For example, group D countries had the fastest and largest reduction in mortality from pneumonia in children aged <5 years. We speculate that this striking decrease is related to the rapid economic development in group D countries (LM-H or UM-H countries) over the study periods. In contrast, group B countries (LM-LM or UM-UM countries) had the slowest and smallest proportion of reduction. Pneumonia deaths are closely associated with overlapping risk factors such as undernutrition, maternal education, and crowded environments [3, 21] . Improvements in socioeconomic development with corresponding increases in maternal education, food supply, and living conditions are important contributors to reductions in childhood pneumonia mortality [22] . Another striking finding is that there were still substantial variations in mortality from pneumonia among countries in 2012. For example, there was a 10-fold differential between mortality from pneumonia in group B countries and in group D countries. This finding sends a clear message to policymakers that inequalities in pneumonia death within countries should not be masked by overall progress. Lower or upper-middle-income countries, such as those from group B, may need to use advanced case management strategies [23] , scale up implementation of new vaccines [24] [25] [26] , and implement other affordable interventions [21] to ensure that their children benefit as much as children in other regions.
Our findings suggest that gender inequality in pneumonia mortality still exists even though significant reductions in pneumonia mortality in both genders were achieved. The observed gender gap is in agreement with previous studies, which indicated that boys are more likely to develop pneumonia and to succumb to it [10, 27] . Our analysis further reveals that the pattern of higher male mortality holds true across time and countries, with rare exceptions (Supplementary Materials Figure 2 ). Previous studies have suggested biological differences, such as anatomical structures [28] [29] [30] , immune responses, or sex hormone levels [31] . In addition, we speculate that this gender discrepancy may also reflect cultural factors, such as a preference to seek medical care and hospital admission for boys [32, Abbreviations: H, high income; LM, low-middle income; UM, upper-middle income. a Trends in this column were identified when there were significant changes in the slopes of the overall trend, which are derived from joinpoint regression. b The bolded values represent significant change.
33], which makes the underlying cause of death from pneumonia more likely to be reported for boys. The apparent disparity of pneumonia mortality between genders warrants further research to seek explanations related to biological or cultural factors, so that corresponding interventions can be developed.
A joinpoint regression analysis of the overall decline of pneumonia mortality from 1960 to 2012 revealed that it was characterized by 3 statistically significant reduction periods. The first significant decline from 1962 to 1965 (17.3% decline per year) was mainly driven by group A countries (Table 2 ). This decline coincided with the availability of the measles vaccine in high-income countries [34] . Measles may be the leading preventable cause of death from childhood pneumonia throughout the world. The measles vaccine was introduced into the United States in 1963, and vaccination programs resulted in a 95% reduction in reported cases of measles [35] . Thus, the significant decline in mortality from pneumonia among children occurred over the same time in which the measles vaccine was likely to have the greatest effect. However, the reasons for the second significant decline from 1972 to 1995 (3.9% decline per year) are likely numerous and cannot be determined by examination of the mortality data alone. Given that the second decline lasted for more than 2 decades, we speculate that this significant decline is probably the result of steady economic growth, political stability, and strengthened interventions [36, 37] . The most recent significant decline, from 1995 to 2012 (8.2% decline per year), was contemporaneous with the implementation of MDG-4, an international development goal aimed at reduced global childhood mortality. Since then, a series of priority interventions have been developed to address MDG-4 targets and reduce childhood mortality [38] [39] [40] . Joinpoint analysis revealed that all national groups except for group A experienced a slowdown in the decline of mortality from pneumonia during the 1980s, but another statistically significant decline began in the late 1980s. Therefore, our findings underscore the timeliness and significance of the MDG-4, which was introduced in the early 1990s when most countries had a slowdown in pneumonia mortality reduction.
To our knowledge, this is the first study to report the trends of observed pneumonia mortality without estimated or extrapolated data in children aged <5 years over 5 decades. In this study, we compiled data from 56 countries with high civil registration coverage. In addition, we were able to perform mortality trend analysis over a long timeframe using joinpoint regression analysis and were able to identify distinct periods of changes in an objective manner.
Several limitations must be considered when interpreting our results. First, our study was constrained to only 56 countries with pneumonia mortality data for at least 30 years. Thus, we could not include very low-income countries in Africa and Asia, in which the burden of childhood pneumonia mortality is the greatest. The exclusion of the countries with the highest childhood mortality may bias the decline trend of pneumonia mortality. Therefore, generalizing the findings to other countries or the global level should be considered with cautions. The quality of mortality data in different countries is another limitation of our study, given that our study included one-fourth of countries with low-quality mortality data. Additionally, quantitative estimates, such as total deaths, and mortality rates, derived from records of vital registration, are most likely to be underestimated because of the incompleteness of vital registration, especially in several lower-middle-income countries. However, even if pneumonia death-recording errors or incompleteness of vital registrations have the potential to influence the observed mortality rates, they should not significantly alter the temporal trends. Last, because of the lack of neonatal population data, our study cannot calculate neonatal pneumonia mortality and its change over time. Our data only reflect the trend of pneumonia mortality for all children aged <5 years; the proportion of under-5 deaths in the neonatal period and its change cannot be directly observed.
The substantial decline of pneumonia mortality in children aged <5 years since 1960 is an encouraging trend, but there are still substantial gaps between different national income transition groups in 2012. Future policies and interventions must extend the success of available strategies from high-income to lower or upper-middle-income regions. Additionally, although our study suggests that a country's economic development is related to the changing trends of pneumonia mortality, economic development reflects the improvement of a combination of various factors that may influence pneumonia mortality. The specific factors and their contributions to the reduction in pneumonia mortality warrant further investigation. Our findings underscore the significance of the implementation of a number of global efforts, such as the MDG-4 and its accompanying interventions. Therefore, continuous monitoring of changes in pneumonia mortality is necessary.
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